109 related articles for article (PubMed ID: 7552282)
1. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
Lee CY; Double KL; Crocker AD
Brain Res; 1995 May; 681(1-2):205-8. PubMed ID: 7552282
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Cox RF; Waszczak BL
Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
[TBL] [Abstract][Full Text] [Related]
3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.
Qin ZH; Weiss B
Eur J Pharmacol; 1994 Sep; 269(1):25-33. PubMed ID: 7828655
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
Undie AS; Berki AC; Beardsley K
Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821
[TBL] [Abstract][Full Text] [Related]
6. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra.
Hemsley KM; Crocker AD
Neuropsychopharmacology; 2001 Oct; 25(4):514-26. PubMed ID: 11557165
[TBL] [Abstract][Full Text] [Related]
7. A new view of the role of dopamine receptors in the regulation of muscle tone.
Crocker AD
Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):846-50. PubMed ID: 8593742
[TBL] [Abstract][Full Text] [Related]
8. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
Mestlin M; McDougall SA
Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
[TBL] [Abstract][Full Text] [Related]
9. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
[TBL] [Abstract][Full Text] [Related]
10. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
11. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
Braun AR; Laruelle M; Mouradian MM
J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Hamblin MW; Creese I
Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
[TBL] [Abstract][Full Text] [Related]
13. Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior.
Yurek DM; Hipkens SB
Brain Res; 1994 Mar; 639(2):329-32. PubMed ID: 7911393
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
15. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
Qin ZH; Chen JF; Weiss B
J Neurochem; 1994 Feb; 62(2):411-20. PubMed ID: 8294904
[TBL] [Abstract][Full Text] [Related]
16. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
Cameron DL; Crocker AD
Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
[TBL] [Abstract][Full Text] [Related]
17. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
Meller E; Bordi F; Bohmaker K
Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
[TBL] [Abstract][Full Text] [Related]
18. The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice.
Quintero GC; Spano D; Lahoste GJ; Harrison LM
Neuroreport; 2008 Oct; 19(16):1563-6. PubMed ID: 18845937
[TBL] [Abstract][Full Text] [Related]
19. The effects of an irreversible dopamine receptor antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), on the regulation of muscle tone in the rat: the role of the substantia nigra.
Hemsley KM; Crocker AD
Neurosci Lett; 1998 Jul; 251(2):77-80. PubMed ID: 9718978
[TBL] [Abstract][Full Text] [Related]
20. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
